Equity / Investment · GCC · Announced 1 Nov 2026

Aram Pharma → Salalah Free Zone

Salalah Free Zone signed an MoU with Aram Pharma for a pharmaceutical secondary-packaging project, part of a wider Omani push to build pharma clusters in three zones.

Parties: Aram Pharma → Salalah Free Zone (Oman)

Value
Undisclosed
Territory
Salalah Free Zone, Oman
Therapeutic area
Other
Asset
Secondary packaging of pharmaceutical products
Announced
1 Nov 2026

Our analysis

Why this matters

On 1 November 2026, Oman's Public Authority for Special Economic Zones and Free Zones announced pharmaceutical and medical-device clusters in three zones: Salalah Free Zone, Risut Industrial City and Khazaen Economic City. At the event, Salalah Free Zone signed two memoranda of understanding. One, with Aram Pharma, covers a project specialised in secondary packaging of pharmaceutical products. The other, with Apex Trans Gulf Manufacturing, covers medical devices. Reported figures put the two MoUs at OMR 30.76 million over 50,000 square metres, but the report does not state Aram's share.

The clusters offer customs exemptions, a 50-year usufruct, up to 30-year tax and financial exemptions and 100% foreign ownership.

The full analysis is free to read with a work email on this page.

Source: Al Roya (Oman)

Latest deals

All GCC deals → · All equity / investment deals → · Browse all emerging-market pharma deals →